News & Events

New federal rule adds transparency to nursing home ownership; VUMC-led research informed rule development

A new federal rule published Nov. 15 will require additional transparency and disclosure of ownership and management of nursing homes across the country, and the rule was shaped by research conducted at Vanderbilt University Medical Center. The rule will help families make more informed decisions about nursing home care, the Centers for Medicare and Medicaid Services said in a news release.

Erves joins Department as director of Community Engaged Research

Jennifer Cunningham Erves, PhD, MPH, MAEd, MS, CHES, has joined Vanderbilt University Medical Center as associate professor of Health Policy, director of Community Engaged Research, Office of Health Equity, and scholar, Vanderbilt Center for Health Services Research.

New study brings patient experience evidence to forefront in Medicare Advantage research

A new study authored by Department of Health Policy PhD student Emma Achola and faculty in the Department is among the first to use self-reported outcomes to help determine the benefit of post-acute care for Medicare and Medicare Advantage beneficiaries. To date, most previous research has relied almost entirely on claims data, which does not fully capture the patient experience. In the study, published recently in JAMA Health Forum, the research team used survey data to determine the usage and outcomes of these individuals after certain acute health events. 

Effective medications for opioid use disorder rarely used

Most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care, according to a research letter published today in JAMA Internal Medicine by lead author Ashley Leech, PhD, assistant professor in the Department of Health Policy at Vanderbilt University Medical Center (VUMC). In 2021, there were more than 100,000 overdose deaths in the United States, with the highest rates among those ages 25-54.

Study Finds Inadequate Use of Recommended Combination Treatment for Miscarriage in the U.S.

A new study published in the Journal of the American Medical Association by researchers at Vanderbilt University Medical Center has found that the recommended two-medication regimen, mifepristone plus misoprostol (similar to that used for induced medication abortion) remains significantly underused despite recommendations to do so from medical professionals

Pair of new research papers highlights variation, benefit of opioid treatment programs

Two new research papers published in the journal Medical Care led by Vanderbilt University Medical Center faculty highlight two different areas related to opioid use treatment in women of reproductive age across several U.S. states. Both studies used similar data and study designs from a randomized field experiment where nearly 4,000 trained callers, either on public health insurance (Medicaid) or private insurance, attempted to seek appointments for treating opioid use disorder across 10 states in the U.S.

Maternal OUD and NOWS increases risk of postneonatal infant mortality

In a new study led by Vanderbilt University Medical Center researchers, infants born to individuals who had opioid use disorder (OUD) during pregnancy or who developed neonatal opioid withdrawal syndrome (NOWS) faced a 54-64% greater risk of postneonatal death than infants without these exposures.